Assessment of Knowledge, Attitude, and Practice on Pharmacovigilance among Unani Stakeholders in India: A Cross-Sectional Study

  • Mohd Aleemuddin Quamri National Institute of Unani Medicine Bangalore
  • Rabia Malik
  • Abdul Wadud National Institute of Unani Medicine, Bangalore, India.
  • Radhika Kunnavil National Institute of Unani Medicine, Bangalore, India.
Keywords: Pharmacovigilance, Knowledge, Attitude, Practice, Unani

Abstract

Aim: To assess the knowledge, attitude, and practice of Pharmacovigilance among Unani stakeholders in India.

Methods: A cross-sectional, non-interventional, questionnaire-based study was conducted among the Unani stakeholders in India. Data was collected online through a Google form-based self-reported questionnaire.

Results: The present study revealed that the average knowledge score of the study participants was 11.36± 3.5(Total score 19). Of the total responders, 47% had a low or very low level of knowledge and 53% had a good or high level of knowledge. There was a positive correlation between KAP scores. Knowledge scores were positively correlated with attitude (r=0.258, p<.001) and practice (r=0.056, p=0.067). Attitude scores were also positively correlated with practice scores (r=0.269, p<.001). These findings suggest that knowledge, attitude, and practice scores showed a weak positive correlation.

Conclusion: This study suggests that the study participants are well-versed in the knowledge of pharmacovigilance, and also have a favorable attitude toward reporting ADRs and misleading advertisements. To implement more effectively the objectives of the pharmacovigilance program of ASU & H Drugs further efforts should be made to increase the practice of pharmacovigilance through awareness programs and on-hand training.

Author Biographies

Mohd Aleemuddin Quamri , National Institute of Unani Medicine Bangalore

Professor, HoD, Dept. of Amraze Jild wa Tazeeniyat, Coordinator, Intermediary Pharmacovigilance     Centre for Unani Drugs, National Institute of Unani Medicine, Bangalore, India.

 

Rabia Malik

Program Associate, Intermediary Pharmacovigilance Centre for Unani Drugs, National Institute of

 Unani Medicine, Bangalore, India.

Abdul Wadud, National Institute of Unani Medicine, Bangalore, India.

Professor, Director, National Institute of Unani Medicine, Bangalore, India.

Radhika Kunnavil, National Institute of Unani Medicine, Bangalore, India.

Assistant Professor in Biostatistics, 

References

Acharya, R., Naik, R., Rang, S., Jani, C. A., & Galib, R. (2022). Knowledge, attitude and practice towards pharmacovigilance among ayurveda physicians and teachers of Gujarat State: A cross-sectional study. Journal of Family Medicine and Primary Care, 11(2), 623.

AYUSH. (2008). Protocol for National Pharmacovigilance Programme for Ayurveda, Siddha and Unani (ASU) drugs. Department of AYUSH, Ministry of Health & Family Welfare, Government of India in collaboration with WHO country office of India, Delhi.

Ayushsuraksha. Pharmacovigilance of Ayurveda, Siddha, Unani, & Homoeopathy (ASU & H) drugs. Available from the following: https://www.ayushsuraksha.com/

Beijer, H. J., & de Blaey, C. J. (2002). Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy world & science : PWS, 24(2), 46–54.

Desai, C. K., Iyer, G., Panchal, J., Shah, S., & Dikshit, R. K. (2011). An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspectives in Clinical research, 2(4), 129. Ring, J., Grosber, M., Möhrenschlager, M., & Brockow, K. (2010). Anaphylaxis: acute treatment and management. Chemical immunology and allergy, 95, 201–210.

Gupta S. K, Nayak S. P. (2015). A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India: observational study. Perspectives in clinical research, 6(1), 45– 52

Hassali, M. A., Shafie, A. A., Saleem, F., Farooqui, M., Haseeb, A., & Aljadhey, H. (2013). A cross-sectional assessment of knowledge, attitude and practice among Hepatitis-B patients in Quetta, Pakistan. BMC Public Health, 13(1), 1-9.

Islam, A. (2018). Origin and development of Unani Medicine: An analytical study. Intellectual Discourse, 26(1), 23-49.

Kharadi, D., Doshi, C. M. (2021). Knowledge, attitude and practice of pharmacovigilance among medical students. International Journal of Basic & Clinical Pharmacology, 10(2), 1–5.

Meher B. R. (2015). A questionnaire-based study to assess knowledge, attitude and practice of pharmacovigilance among undergraduate medical students in a Tertiary Care Teaching Hospital of South India. Perspectives in clinical research, 6(4), 217–21

Muraraiah, S., Rajarathna, K., Sreedhar, D., Basavalingu, D., & Jayanthi, C. R. (2011). A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre. J Chem Pharm Res, 3(6), 416-22.

Rahman, S. Z., Khan, R. A., & Latif, A. (2008). Importance of pharmacovigilance in Unani system of medicine. Indian Journal of pharmacology, 40(Suppl1), S17.

Sina, I. (2010). Al Qanoon fit tibb (Urdu translation by Kanturi GH) Vol. II. New Delhi: Ejaz publishing house, 282, 291,314,459

WHO. (2004). WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. World Health Organization.

WHO. (2005). Committee of Experts on Management of Safety and Quality in Health Care (SP-SQS) Expert Group on Safe Medication Practices. Glossary of Terms Related to Patient and Medication Safety: World Health Organization, p. 13.

Published
2022-12-01
How to Cite
1.
Quamri MA, Malik R, Wadud A, Kunnavil R. Assessment of Knowledge, Attitude, and Practice on Pharmacovigilance among Unani Stakeholders in India: A Cross-Sectional Study. jpadr [Internet]. 2022Dec.1 [cited 2023Feb.5];3(4):15-2. Available from: https://jpadr.com/index.php/jpadr/article/view/110